$5.80
-0.33-5.38%
At close: -
$6.13
0.335.69%
After Hours: Apr 3, 4:01 PM EDT
Comments
Loading...
Contineum Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:CTNM | Benzinga
Contineum Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS
$-0.560
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Contineum Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics | -$3.55 | — | — | — | $0.00 | — | — | — | 05/16/2025 | Get Alert |
| CTNM | Contineum Therapeutics | -$3.32 | -$0.44 | -$0.56 | -27.27% | $0.00 | — | $0.00 | — | 03/06/2025 | Get Alert |
| CTNM | Contineum Therapeutics | -$2.69 | -$0.43 | -$0.40 | 6.98% | — | — | $0.00 | — | 11/06/2024 | Get Alert |
| CTNM | Contineum Therapeutics | $0.84 | -$0.35 | -$0.39 | -11.43% | $50.00K | — | $0.00 | — | 08/13/2024 | Get Alert |
| CTNM | Contineum Therapeutics | -$2.12 | — | -$3.55 | — | $0.00 | — | $0.00 | — | 05/16/2024 | Get Alert |
Contineum Therapeutics (CTNM) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-06 | $-0.56 | $-0.44 | -27.3 % |
| Q3 | 2024-11-06 | $-0.40 | $-0.43 | 6.98 % |
| Q2 | 2024-08-13 | $-0.39 | $-0.35 | -11.4 % |
Contineum Therapeutics (CTNM) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
FAQ
When is Contineum Therapeutics (NASDAQ:CTNM) reporting earnings?
Contineum Therapeutics (CTNM) is scheduled to report earnings on May 16, 2025. The last reported earnings were for reported on March 6, 2025 for Q4.
What were the latest earnings per share (EPS) for Contineum Therapeutics (NASDAQ:CTNM)?
The Actual EPS was $-0.56, which missed the estimate of $-0.44.
What were Contineum Therapeutics’s (NASDAQ:CTNM) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.